Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Moro RN"'
Autor:
Yasushi Ueki, MD, Benjamin Vögeli, BA, Alexios Karagiannis, PhD, Thomas Zanchin, MD, Christian Zanchin, MD, Daniel Rhyner, MD, Tatsuhiko Otsuka, MD, Fabien Praz, MD, George C.M. Siontis, MD, PhD, Christina Moro, RN, Stefan Stortecky, MD, Michael Billinger, MD, Marco Valgimigli, MD, PhD, Thomas Pilgrim, MD, Stephan Windecker, MD, Thomas Suter, MD, Lorenz Räber, MD, PhD
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 2, Pp 145-155 (2019)
Objectives: The purpose of this study was to evaluate ischemic and bleeding outcomes of unselected cancer patients undergoing percutaneous coronary intervention (PCI). Background: The number of cancer patients undergoing PCI is increasing despite con
Externí odkaz:
https://doaj.org/article/0f37b5e1525a4326be791973daa1a78e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moro RN; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mehaffy C; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA., De P; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA., Phillips E; Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Borisov AS; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sterling TR; Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Dobos KM; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. 1271-1278.
Interferon restores replication fork stability and cell viability in BRCA-defective cells via ISG15.
Autor:
Moro RN; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Biswas U; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Kharat SS; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, 21702, MD, USA., Duzanic FD; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Das P; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015GD, Rotterdam, the Netherlands., Stavrou M; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Raso MC; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Freire R; Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, 38200, La Laguna, Spain.; Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain., Chaudhuri AR; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015GD, Rotterdam, the Netherlands., Sharan SK; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, 21702, MD, USA., Penengo L; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland. penengo@imcr.uzh.ch.
Publikováno v:
Nature communications [Nat Commun] 2023 Oct 02; Vol. 14 (1), pp. 6140. Date of Electronic Publication: 2023 Oct 02.
Autor:
Sadowski C; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA., Belknap R; Denver Metro Tuberculosis Program, Denver Public Health, Denver, Colorado, USA., Holland DP; Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA., Moro RN; CDC Foundation, Research Collaboration, Atlanta, Georgia, USA.; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chen MP; Immunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wright A; Division of Infectious Diseases, Vanderbilt University Medical Centers, Nashville, Tennessee, USA., Millet JP; Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain., Caylà JA; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain., Scott NA; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Borisov A; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gandhi NR; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jun 16; Vol. 76 (12), pp. 2090-2097.
Autor:
Scott NA; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA. Electronic address: NScott@cdc.gov., Sadowski C; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA; Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA., Vernon A; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA., Arevalo B; Westat, Rockville, MD, USA., Beer K; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA., Borisov A; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA., Cayla JA; Foundation of TB Research Unit of Barcelona, Barcelona, Spain., Chen M; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA., Feng PJ; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA., Moro RN; U.S. Centers for Disease Control & Prevention, Atlanta, GA, USA., Holland DP; Emory University, Atlanta, GA, USA., Martinson N; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, South Africa and Johns Hopkins University Center for TB Research, Baltimore, MD, USA., Millet JP; Agència de Salut Pública de Barcelona, Spain; CIBER de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain., Miro JM; Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Belknap R; Public Health Institute at Denver Health, Denver, CO, USA.
Publikováno v:
Contemporary clinical trials [Contemp Clin Trials] 2023 Jun; Vol. 129, pp. 107173. Date of Electronic Publication: 2023 Mar 31.
Autor:
Mital R; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.; College of Medicine, The Ohio State University, Columbus, Ohio, USA., Lovegrove MC; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Moro RN; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Geller AI; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Weidle NJ; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.; Eagle Global Scientific, LLC (contractor to CDC), Atlanta, Georgia, USA., Lind JN; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Budnitz DS; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2022 Feb; Vol. 31 (2), pp. 225-234. Date of Electronic Publication: 2021 Nov 24.
Autor:
Moro RN; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Northrop Grumman Corporation, Atlanta, Georgia., Geller AI; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Weidle NJ; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Eagle Global Scientific, LLC, Atlanta, Georgia., Lind JN; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Lovegrove MC; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Rose KO; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Northrop Grumman Corporation, Atlanta, Georgia., Goring SK; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Northrop Grumman Corporation, Atlanta, Georgia., McAninch JK; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Dowell D; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia., Budnitz DS; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: dbudnitz@cdc.gov.
Publikováno v:
American journal of preventive medicine [Am J Prev Med] 2020 Apr; Vol. 58 (4), pp. 526-535. Date of Electronic Publication: 2020 Feb 20.
Autor:
Shehab N; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Ziemba R; Pharmacy and Quality Measurement Division, Health Services Advisory Group, Inc., Tampa, Florida., Campbell KN; Pharmacy and Quality Measurement Division, Health Services Advisory Group, Inc., Tampa, Florida., Geller AI; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Moro RN; Northrop Grumman Corporation, contractor to the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Gage BF; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Budnitz DS; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Yang TH; Pharmacy and Quality Measurement Division, Health Services Advisory Group, Inc., Tampa, Florida.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2019 Jul; Vol. 28 (7), pp. 951-964. Date of Electronic Publication: 2019 May 29.
Autor:
Njie GJ; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: gnjie@cdc.gov., Morris SB; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Woodruff RY; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Moro RN; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia; CDC Foundation Research Collaboration, Atlanta, Georgia., Vernon AA; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Borisov AS; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Publikováno v:
American journal of preventive medicine [Am J Prev Med] 2018 Aug; Vol. 55 (2), pp. 244-252. Date of Electronic Publication: 2018 Jun 14.